Recursion Pharmaceuticals, Inc. - RXRX

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Biological Products, (no Disgnostic Substances)
Latest data: 3/19/2026 10:04:25 PM
EDGAR CIK 0001601830

Buy Breakdown

Total $0

Sell Breakdown

Total $5,272,916

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
03/17/2026
10b5-1
03/18/2026
Taylor Ben R
Chief Financial Officer
CFO
Sell
-7,956 @ $3.39
($26,970.84)
 1,180,318 (-0.67%) Direct
03/09/2026
10b5-1
03/11/2026
Khan Najat
CEO and President
CEO Director
Sell
-28,298 @ $3.35
($94,659.64)
 2,262,085 (-1.24%) Direct
03/03/2026
03/04/2026
Borgeson Blake
Director
Sell
-170,000 @ $3.46
($588,200.00)
 6,259,863 (-2.64%) Direct
02/18/2026
10b5-1
02/19/2026
Taylor Ben R
Chief Financial Officer
CFO
Sell
-13,426 @ $3.08
($41,352.08)
 1,195,349 (-1.11%) Direct
02/03/2026
10b5-1
02/06/2026
Borgeson Blake
Director
Sell
-220,000 @ $4.20
($924,000.00)
 6,429,863 (-3.31%) Direct
01/06/2026
10b5-1
01/08/2026
Borgeson Blake
Director
Sell
-220,000 @ $4.36
($959,200.00)
 6,649,863 (-3.20%) Direct
12/29/2025
10b5-1
12/30/2025
Taylor Ben R
Chief Financial Officer
CFO
Sell
-21,383 @ $4.18
($89,380.94)
 761,550 (-2.73%) Direct
12/22/2025
10b5-1
12/29/2025
Khan Najat
Chief R&D Commercial Officer
Officer Director
Sell
-124,403 @ $4.41
($548,592.35)
 611,135 (-16.91%) Direct
12/02/2025
10b5-1
12/04/2025
Borgeson Blake
Director
Sell
-220,000 @ $4.37
($961,400.00)
 6,869,863 (-3.10%) Direct
08/18/2025
08/19/2025
Khan Najat
Chief R&D Commercial Officer
Officer Director
Sell
-36,599 @ $5.52
($202,172.88)
 668,197 (-5.19%) Direct
03/27/2025
10b5-1
03/28/2025
Gibson Christopher
Chief Executive Officer
CEO Director
Sell
-138,574 @ $6.04
($836,986.96)
 1,117,450 (-11.03%) Direct